NTRK positivity and conversion to appropriate personalized treatment.
26 Jul 2024
NTRK positivity and conversion to appropriate personalized treatment.
Bethany Michelle Slifko, Howard L. McLeod, Wendy Moore, Inês Abrunhosa Amaral, Susanne Munksted
Our ASCO 2024 abstract is now available!
This study examines the challenges in ensuring patients with NTRK alterations receive appropriate targeted treatments despite the effectiveness of available drugs, and emphasizes the need for improved strategies.
Click the link below to access the abstract